Pfizer’s Strategic Masterstroke in the Obesity Drug Arena
In a landmark corporate acquisition, pharmaceutical titan Pfizer has successfully outmaneuvered competitor Novo Nordisk, securing the prized drug developer Metsera...
My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers.
My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world.
A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses.
In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.
In a landmark corporate acquisition, pharmaceutical titan Pfizer has successfully outmaneuvered competitor Novo Nordisk, securing the prized drug developer Metsera...
The landscape of quantum computing is rapidly evolving, with IonQ and Rigetti Computing emerging as prominent contenders in this pioneering...
The global food conglomerate Kraft Heinz continues to face significant headwinds, with recent quarterly results amplifying investor concerns. As the...
Eli Lilly's ambitious push into artificial intelligence is generating significant excitement across Wall Street. The pharmaceutical giant's recent alliance with...
The future of Express stock appears increasingly bleak as the company faces potential removal from public trading. Designated as "potentially...
The financial outlook for Ocugen has grown increasingly precarious, with the biotechnology firm's stock extending losses for five consecutive trading...
Polar Power shares are entering a pivotal week as investors brace for the company's upcoming quarterly report. The stock faces...
The investment community is watching closely as Stereotaxis, a pioneer in robotic medical technology, prepares to release its quarterly earnings....
A severe clinical setback has triggered a massive sell-off in Intellia Therapeutics stock, with shares plummeting more than 22% during...
The shares of Canadian artificial intelligence specialist Healwell AI are attracting significant market attention following a period of transformative corporate...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com